Sign In
Buy IMCR
$29.20
-0.150 (-0.511%)
At Close: Jun 23, 2026
Immunocore to Report Second Quarter 2022 Earnings and Host Call on August 10, 2022
07:00am, Wednesday, 03'rd Aug 2022
Immunocore to Report Second Quarter 2022 Earnings and Host Call on August 10, 2022
Is Immunocore (IMCR) Outperforming Other Medical Stocks This Year?
11:21am, Tuesday, 02'nd Aug 2022
Here is how Immunocore Holdings PLC Sponsored ADR (IMCR) and Jazz Pharmaceuticals (JAZZ) have performed compared to their sector so far this year.
5 Stocks With Recent Price Strength to Gain From July Rally
06:59am, Wednesday, 27'th Jul 2022
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are IMCR, FC, ASC, SNEX and ARLP.
Wall Street Analysts Think Immunocore Holdings PLC Sponsored ADR (IMCR) Could Surge 29%: Read This Before Placing a Bet
11:35am, Monday, 25'th Jul 2022
The consensus price target hints at a 29.4% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upwa
Immunocore - Healthcare Biotech
10:15pm, Wednesday, 20'th Jul 2022
100% technical buy signals. 13 new highs and up 38.33% in the last month.
What's Winning in 2022? 3 Stocks That Are Doing Fine
06:00am, Saturday, 16'th Jul 2022
Immunocore, Axsome Therapeutics, and Takeda are significantly outperforming the market this year.
Here's Why "Trend" Investors Would Love Betting on Immunocore Holdings PLC Sponsored ADR (IMCR)
10:05am, Monday, 11'th Jul 2022
If you are looking for stocks that are well positioned to maintain their recent uptrend, Immunocore Holdings PLC Sponsored ADR (IMCR) could be a great choice. It is one of the several stocks that pass
5 Stocks With Recent Price Strength to Maximize Your Gains
08:38am, Friday, 24'th Jun 2022
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are IMCR, UFCS, CWCO, HURN and FCN.
4 Biotech Stocks With Bright Prospects to Buy Amid Recovery
01:33pm, Friday, 10'th Jun 2022
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline progress position ALKS, GERN, IMC
Immunocore (IMCR) Up on Deal With Sanofi for Skin Cancer Study
11:18am, Monday, 06'th Jun 2022
Immunocore (IMCR) signs a collaboration agreement with Sanofi to study the combination of Kimmtrak with the latter's SAR444245 for treating metastatic cutaneous melanoma. Shares up.
Immunocore to present at upcoming investor conferences
04:30pm, Wednesday, 01'st Jun 2022
Immunocore to present at upcoming investor conferences
Immunocore to present at the 21st Annual Needham Healthcare Conference
07:00am, Thursday, 07'th Apr 2022
Immunocore to present at the 21 st Annual Needham Healthcare Conference
3 CEOs to Invest In
09:00pm, Friday, 01'st Apr 2022
Looking for a healthcare stock with strong leadership? Our roundtable likes Immunocore, Axsome Therapeutics, and GlaxoSmithKline.
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves to Buy: Rationale Behind the Upgrade
01:32pm, Wednesday, 16'th Mar 2022
Immunocore Holdings PLC Sponsored ADR (IMCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the ne
Wall Street Analysts See a 135% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
11:17am, Wednesday, 16'th Mar 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 134.8% in Immunocore Holdings PLC Sponsored ADR (IMCR). While the effectiveness of this highly sought-after met
